
Work Here?
Work Here?
Work Here?
Level Zero Health develops a biosensor platform for remote, continuous hormone monitoring. Its core product is a minimally invasive arm patch that uses DNA-based biosensors and microneedles to measure hormones such as estrogen, progesterone, cortisol, and testosterone in interstitial fluid. The patch attaches to the skin, accesses interstitial fluid with microneedles, and converts hormone levels into electronic signals sent to a connected system for real-time tracking integrated into clinical workflows. The company differentiates itself with continuous, real-time data from a wearable platform focused on women's health, validated at 98% accuracy in simulated clinical ranges, and pursuing FDA and CE approvals to enable IVF, menopause management, and testosterone replacement therapy applications. Its goal is to move hormone tracking from infrequent tests to continuous data streams to support better clinical decisions, with plans to expand into consumer and pharmaceutical markets.
Industries
Data & Analytics
Biotechnology
Healthcare
Company Size
11-50
Company Stage
Seed
Total Funding
$6.9M
Headquarters
San Francisco, California
Founded
2023
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$6.9M
Above
Industry Average
Funded Over
1 Rounds
Industry standards
Company Equity
A new generation of HealthTech startups is emerging across Europe, redefining how we access, monitor, and manage our wellbeing. By harnessing digital solutions and software-driven technologies, these innovators are enhancing patient care, supporting medical professionals, and advancing developments in biotech and pharmaceuticals. From AI-powered diagnostics to remote monitoring and personalised treatment tools, they are shifting HealthCare from hospital walls to everyday life.This convergence of HealthTech, biotech, and pharma is also reflected in investment trends, with combined VC funding reaching over €60 billion globally in 2024, making it the second-largest VC category after enterprise software. AI-led drug discovery stands out as a key area of focus, while digital therapeutics have become the fastest-growing HealthTech segment since 2017, according to Dealroom’s HealthTech report.In the list below, we spotlight 20 exceptionally promising early-stage HealthTech startups from across Europe. Founded between 2022 and 2025, these startups are moving beyond traditional MedTech by developing accessible tools for prevention, remote care, and personalised wellbeing.Adsilico: Founded in 2022, this UK-based HealthTech startup is transforming medical device development through advanced computational modelling and AI-driven simulations. By creating high-fidelity virtual patients, they enable in-silico trials that assess device safety and efficacy before human testing
UK-based healthtech start-up Level Zero Health has raised $6.9 million (£5.5 million) in pre-seed funding, marking the largest amount ever secured by female founders in Europe. Led by Redalpine, the investment will support the development of a pioneering remote hormone monitoring device. Founded by Ula Rustamova and Irene Jia, the company aims to revolutionize hormone tracking with a non-invasive wearable patch. The funding will advance R&D and expand the team, with plans to enter consumer health markets.
London-based HealthTech startup Level Zero Health today announced a €6.6 million pre-Seed funding round to enable remote and continuous hormone monitoring, using unique DNA-based sensors.
Level Zero Health, a female-founded medical device startup that's aiming to break new ground by developing a device for continuous hormone monitoring, has
UK and us-based Level Zero Health raises €6.63M to develop the first remote hormone monitoring device.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Biotechnology
Healthcare
Company Size
11-50
Company Stage
Seed
Total Funding
$6.9M
Headquarters
San Francisco, California
Founded
2023
Find jobs on Simplify and start your career today